These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 24941874
1. The identification of high-affinity G protein-coupled receptor ligands from large combinatorial libraries using multicolor quantum dot-labeled cell-based screening. Fu J, Lee T, Qi X. Future Med Chem; 2014 May; 6(7):809-23. PubMed ID: 24941874 [Abstract] [Full Text] [Related]
2. Emerging Approaches to GPCR Ligand Screening for Drug Discovery. Kumari P, Ghosh E, Shukla AK. Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827 [Abstract] [Full Text] [Related]
3. GPCR profiling: from hits to leads and from genotype to phenotype. Cvijic ME, Sum CS, Alt A, Zhang L. Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890 [Abstract] [Full Text] [Related]
9. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. Gruber CW, Muttenthaler M, Freissmuth M. Curr Pharm Des; 2010 Nov; 16(28):3071-88. PubMed ID: 20687879 [Abstract] [Full Text] [Related]
10. G-protein-coupled receptor-focused drug discovery using a target class platform approach. Heilker R, Wolff M, Tautermann CS, Bieler M. Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411 [Abstract] [Full Text] [Related]
12. Synthesis and screening of bead-displayed combinatorial libraries. Doran TM, Dickson P, Ndungu JM, Ge P, Suponitsky-Kroyter I, An H, Kodadek T. Methods Enzymol; 2019 Mar; 622():91-127. PubMed ID: 31155067 [Abstract] [Full Text] [Related]
13. High throughput screening (HTS) in identification new ligands and drugable targets of G protein-coupled receptors (GPCRs). Wang D, Li Y, Zhang Y, Liu Y, Shi G. Comb Chem High Throughput Screen; 2012 Mar; 15(3):232-41. PubMed ID: 22221056 [Abstract] [Full Text] [Related]
14. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development. Hurevich M, Talhami A, Shalev DE, Gilon C. Curr Top Med Chem; 2014 Mar; 14(15):1842-63. PubMed ID: 25175995 [Abstract] [Full Text] [Related]